Boston Scientific to buy rest of Rubicon for about $72 mln
Thu Apr 14, 2005 07:28 AM ET(wonder why its above the offer price)
NEW YORK, April 14 (Reuters) - Medical device maker Boston Scientific Corp. (BSX.N: Quote, Profile, Research) said on Thursday it agreed to acquire the rest of Rubicon Corp., (RMDC.OB: Quote, Profile, Research) a maker of vascular medical products, for about $71.7 million.
If all post-acquisition milestones are met, Boston Scientific could pay an additional $83.7 million.
Boston Scientific, which already owns more than half of Rubicon, said it exercised its option to acquire Rubicon shares held by Rubicon's principal stockholders. The action triggered Boston Scientific's obligation to begin a cash tender offer for the remaining shares of Rubicon's stock for $1.50 a share, with other potential payments of $1.44 a share.